Trexquant Investment LP Sells 60,964 Shares of Enhabit, Inc. (NYSE:EHAB)

Trexquant Investment LP trimmed its position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 29.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 142,695 shares of the company's stock after selling 60,964 shares during the period. Trexquant Investment LP owned 0.28% of Enhabit worth $1,114,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Franklin Resources Inc. boosted its holdings in Enhabit by 19.6% in the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company's stock worth $256,000 after buying an additional 5,317 shares during the period. JPMorgan Chase & Co. grew its position in shares of Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock valued at $2,411,000 after purchasing an additional 83,707 shares in the last quarter. Paradice Investment Management LLC raised its stake in shares of Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after purchasing an additional 201,997 shares during the period. XTX Topco Ltd purchased a new stake in Enhabit during the 3rd quarter worth about $123,000. Finally, Rhumbline Advisers boosted its stake in Enhabit by 2.8% in the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after purchasing an additional 2,211 shares during the period.

Enhabit Price Performance

EHAB stock traded down $0.07 during midday trading on Wednesday, reaching $7.72. The company had a trading volume of 36,800 shares, compared to its average volume of 320,284. The firm has a 50-day moving average price of $8.46 and a 200-day moving average price of $7.99. The company has a market capitalization of $389.71 million, a P/E ratio of -3.33 and a beta of 1.60. Enhabit, Inc. has a 1 year low of $6.85 and a 1 year high of $10.70. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reiterated a "buy" rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.